Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: All Other Nonoperating Income (Expense)
QFRD110385USNO • Economic Data from Federal Reserve Economic Data (FRED)
Latest Value
10,175.00
Year-over-Year Change
59.26%
Date Range
10/1/2000 - 4/1/2025
Summary
Tracks nonoperating income and expenses for U.S. pharmaceutical corporations. Provides insight into financial performance beyond core business operations.
Analysis & Context
This economic indicator provides valuable insights into current market conditions and economic trends. The data is updated regularly by the Federal Reserve and represents one of the most reliable sources for economic analysis.
Understanding this metric helps economists, policymakers, and investors make informed decisions about economic conditions and future trends. The interactive chart above allows you to explore historical patterns and identify key trends over time.
About This Dataset
This metric captures additional financial activities outside primary pharmaceutical business revenue. It helps analysts understand comprehensive corporate financial health.
Methodology
Collected quarterly through comprehensive corporate financial reporting surveys.
Historical Context
Used by investors and financial analysts to assess pharmaceutical company financial strategies.
Key Facts
- Quarterly reporting metric for pharmaceutical corporations
- Includes income from investments and non-core activities
- Critical for comprehensive financial analysis
FAQs
Q: What does nonoperating income mean for pharmaceutical companies?
A: Represents financial gains outside core business operations. Includes investments, asset sales, and other peripheral income sources.
Q: How often is this financial data updated?
A: Reported quarterly by the U.S. Federal Reserve. Provides current snapshot of pharmaceutical corporate finances.
Q: Why do investors care about nonoperating income?
A: Reveals additional revenue streams and financial management strategies beyond primary business activities.
Q: How does this metric differ from operating income?
A: Captures financial activities not directly related to primary pharmaceutical business operations.
Q: Are there limitations to this financial reporting?
A: Represents a snapshot in time and should be analyzed alongside other financial indicators.
Related News
Gen Z In the U.S. Shifts From Spending To Saving Habits
How Gen Z's Shift from Spending to Saving is Impacting the US Economy Recent trends indicate a significant shift in the spending habits of Gen Z, w...
U.S. Treasury Yields Decline After Inflation Data Meet Expectations
US Treasury Yields Drop as Inflation Data Meets Expectations US Treasury yields have seen a noticeable decline recently, as the latest inflation da...
S&P 500 Rises With Optimistic U.S. Inflation Report
S&P 500 Soars: Positive U.S. Inflation Developments The S&P 500, a primary stock index that tracks the performance of 500 major U.S. companies, has...
U.S. Stock Market Rises Amid PCE Inflation Report Analysis
U.S. Stock Market Climbs Amidst Insights from PCE Inflation Report Investors in the U.S. stock market are focusing on the most recent PCE Inflation...
U.S. GDP Growth to Slow Due to Tariffs and Immigration Policies
How Tariffs and Immigration Policies Influence U.S. GDP Growth in 2025 The U.S. GDP is a fundamental gauge of the country's economic health. Recent...
U.S. Stock Market Futures Rise On Inflation and Tariff News
US Stock Market Futures Rise Amid Inflation Data and Tariff News US stock market futures are on the rise, driven by significant updates in inflatio...
Related Trends
Quarterly Financial Report: U.S. Corporations: Apparel and Leather Products: Inventories
QFR214ANLUSNO
Contributions to the Chicago Fed Relative Midwest Economy Index: Midwest Region Contribution
RREGIONALM683SFRBCHI
Quarterly Financial Report: U.S. Corporations: Computer Systems Design and Related Services: Net Income Retained in Business
QFRNIRB545USNO
Quarterly Financial Report: U.S. Corporations: Wholesale Trade, Durable Goods: Net Property, Plant, and Equipment
QFR219421USNO
Quarterly Financial Report: U.S. Corporations: Wholesale Trade, Durable Goods: Retained Earnings at Beginning of Quarter
QFRD119421USNO
Quarterly Financial Report: U.S. Corporations: Transportation Equipment: Income (Loss) After Income Taxes
QFR115TRAUSNO
Citation
U.S. Federal Reserve, Quarterly Financial Report: Pharmaceuticals and Medicines Nonoperating Income (QFRD110385USNO), retrieved from FRED.